WebQ4 2024. Regeneron Reports Fourth Quarter and Full Year 2024 Financial and Operating Results. Regeneron Corporate Presentation February 2024. Q4 2024 Earnings Conference Call Transcript. Form 10-K. WebApr 12, 2024 · South San Francisco, CA -- April 12, 2024 --. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data for its approved and investigational medicines will be highlighted in 30 abstracts at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, which …
Bicycle Therapeutics Announces Expansion of Genentech Immuno …
WebFeb 8, 2024 · Investors. Press Releases; Events & Presentations; Corporate Governance. Charters and Documents; Leadership; ... Genentech and Lineage are working together to expand benefits of cell … WebApr 11, 2024 · GENENTECH, INC. Fortescue Metals Group Limited Reports Unaudited Consolidated Earnings and Production Results for the Half Year Ended December 31, 2014; Provides Production Guidance for … christopher gill mvp
Roche US investors
WebInvestors. Roche’s 1st Quarter Sales 2024 Webinar. Wednesday, 26th April 2024, 14:00 CEST. More details. ... Genentech has been delivering on the promise of biotechnology … Web1 day ago · Patients may also report side effects to Genentech at (888) 835-2555. ... Investor Contacts: Loren Kalm, (650) 225-3217 Bruno Eschli, +41 61 687 5284 Contacts. WebCURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2006 GENENTECH, … christopher gimbo